CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

Core Insights - CytoSorbents Corporation has launched a newly redesigned website that serves as a comprehensive information hub for healthcare professionals, investors, and other stakeholders, emphasizing the theme "Working to Save Lives Together" [1][5][11] Company Overview - CytoSorbents Corporation is a leader in blood purification technologies aimed at treating life-threatening conditions in intensive care and cardiac surgery, with its flagship product, CytoSorb®, approved in the EU and distributed in 75 countries [11] - The company has developed various products based on proprietary polymer adsorption technology, which has received approximately $50 million in funding from multiple U.S. government agencies [8][11] Website Features - The new website features a user-friendly layout optimized for both desktop and mobile, providing easy access to essential information [2] - It includes a comprehensive resource library with over 1,000 peer-reviewed publications and other materials related to the company's therapies [2] - The site also offers dedicated sections for news updates, investor relations, and improved contact forms for faster communication [2] Product Information - CytoSorb® is designed to reduce cytokine storms in critical illnesses, with over 237,000 devices used cumulatively as of March 31, 2024 [11] - The DrugSorb™-ATR system, an investigational device, has received two FDA Breakthrough Device Designations for removing specific anticoagulants during cardiothoracic procedures [12]